These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11922233)

  • 21. Therapeutic advances in acute ischaemic stroke.
    Bhalla A; Rudd AG
    Int J Clin Pract; 1999 Jun; 53(4):295-300. PubMed ID: 10563075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the brain: neuroprotection and neurorestoration in ischemic stroke.
    Saver JL
    Pharmacotherapy; 2010 Jul; 30(7 Pt 2):62S-9S. PubMed ID: 20575624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ancrod.
    Sherman DG
    Curr Med Res Opin; 2002; 18 Suppl 2():s48-52. PubMed ID: 12365829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolving therapeutic approaches to treating acute ischemic stroke.
    Weinberger JM
    J Neurol Sci; 2006 Nov; 249(2):101-9. PubMed ID: 17005205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Admission international normalized ratio and acute infarct volume in ischemic stroke.
    Ay H; Arsava EM; Gungor L; Greer D; Singhal AB; Furie KL; Koroshetz WJ; Sorensen AG
    Ann Neurol; 2008 Nov; 64(5):499-506. PubMed ID: 18661516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neuroprotective role of erythropoietin in the management of acute ischaemic stroke: from bench to bedside.
    Ntaios G; Savopoulos C; Chatzinikolaou A; Hatzitolios AI
    Acta Neurol Scand; 2008 Dec; 118(6):362-6. PubMed ID: 18513348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of heparin and low-molecular-weight heparins in the management of acute ischemic stroke.
    Padma V; Fisher M; Moonis M
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):405-15. PubMed ID: 16716101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin in acute ischemic stroke revisited.
    Chamorro A
    Rev Neurol (Paris); 2008 Oct; 164(10):815-8. PubMed ID: 18778842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete].
    García-García J; Gracia-Gil J; Sopelana-Garay D; Ayo-Martín O; Vadillo-Bermejo A; Touza B; Peñalver-Pardines C; Zorita MD; Segura T
    Rev Neurol; 2008 Jan 1-15; 46(1):7-12. PubMed ID: 18214820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracerebral haemorrhage revisited.
    Dickinson CJ
    QJM; 2007 Nov; 100(11):715-9. PubMed ID: 17951316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteplase for acute ischemic stroke.
    Gonzales NR; Grotta JC
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):301-18. PubMed ID: 16716092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FPIN's clinical inquiries. Aspirin in patients with acute ischemic stroke.
    Park MK; Smith PC; Wanserski G; Neher JO
    Am Fam Physician; 2009 Feb; 79(3):226-7. PubMed ID: 19202970
    [No Abstract]   [Full Text] [Related]  

  • 33. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.
    Candelario-Jalil E
    Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EMS mythology. EMS myth #2. Thombolytic therapy is the standard of care for acute ischemic stroke.
    Bledsoe BE
    Emerg Med Serv; 2003 Apr; 32(4):63-5. PubMed ID: 12705219
    [No Abstract]   [Full Text] [Related]  

  • 35. Is it time to definitely abandon neuroprotection in acute ischemic stroke?
    Sacchetti ML
    Stroke; 2008 Jun; 39(6):1659-60. PubMed ID: 18369169
    [No Abstract]   [Full Text] [Related]  

  • 36. Ancrod for acute ischemic stroke: a new dosing regimen derived from analysis of prior ancrod stroke studies.
    Levy DE; Trammel J; Wasiewski WW;
    J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):23-7. PubMed ID: 19110140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recanalization and reperfusion therapies for acute ischemic stroke.
    Molina CA; Alvarez-Sabín J
    Cerebrovasc Dis; 2009; 27 Suppl 1():162-7. PubMed ID: 19342847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective.
    Chan YF; Kwiatkowski TG; Rella JG; Rennie WP; Kwon RK; Silverman RA
    J Emerg Med; 2005 Nov; 29(4):405-8. PubMed ID: 16243196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices.
    Savitz SI; Benatar M; Saver JL; Fisher M
    Cerebrovasc Dis; 2008; 26(2):156-62. PubMed ID: 18560219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Third generation thrombolytics for the treatment of ischemic stroke.
    Qureshi AI; Pande RU; Kim SH; Hanel RA; Kirmani JF; Yahia AM
    Curr Opin Investig Drugs; 2002 Dec; 3(12):1729-32. PubMed ID: 12528307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.